PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q1 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,134,473 | +25.0% | 2,911,255 | +1.2% | 0.00% | – |
| Q2 2023 | $3,307,618 | +18.3% | 2,876,190 | +9.0% | 0.00% | – |
| Q1 2023 | $2,795,925 | +97149.6% | 2,637,666 | +39.4% | 0.00% | – |
| Q4 2022 | $2,875 | -99.9% | 1,891,714 | +1.2% | 0.00% | -100.0% |
| Q3 2022 | $3,963,000 | +71.8% | 1,869,372 | +8.6% | 0.00% | – |
| Q2 2022 | $2,307,000 | -36.7% | 1,721,672 | -0.4% | 0.00% | – |
| Q1 2022 | $3,647,000 | -44.1% | 1,728,560 | -1.7% | 0.00% | -100.0% |
| Q4 2021 | $6,520,000 | -16.6% | 1,757,672 | +12.2% | 0.00% | 0.0% |
| Q3 2021 | $7,815,000 | -34.3% | 1,566,286 | -14.2% | 0.00% | -50.0% |
| Q2 2021 | $11,901,000 | +15.9% | 1,825,435 | +22.5% | 0.00% | 0.0% |
| Q1 2021 | $10,270,000 | -13.2% | 1,490,659 | +28.5% | 0.00% | 0.0% |
| Q4 2020 | $11,835,000 | +224.7% | 1,160,339 | +11.4% | 0.00% | +100.0% |
| Q3 2020 | $3,645,000 | -35.5% | 1,041,492 | -8.0% | 0.00% | 0.0% |
| Q2 2020 | $5,649,000 | +42.5% | 1,132,201 | -2.9% | 0.00% | 0.0% |
| Q1 2020 | $3,965,000 | – | 1,166,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |